An Open Label Phase I Substudy to Evaluate the Safety and Ability to Enhance Immunogenicity of ND1.1 by Delivery Directly to the Ileum Using the InteliSite Companion Capsule in Healthy Adult Males [Substudy of 700054364]

Trial Profile

An Open Label Phase I Substudy to Evaluate the Safety and Ability to Enhance Immunogenicity of ND1.1 by Delivery Directly to the Ileum Using the InteliSite Companion Capsule in Healthy Adult Males [Substudy of 700054364]

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jul 2015

At a glance

  • Drugs Influenza A virus vaccine-H5N1 (Primary)
  • Indications Influenza A virus H5N1 subtype
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Jul 2015 Data will be presented at the Society for Mucosal Immunology Conference 2015, according to a Vaxart media release.
    • 09 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top